Axsome Therapeutics had a revenue of 170.99M in the quarter ending Sep 30, 2025, with 13.96%. This bring the company's revenue in the last twelve months to 561.26M, Decreased 13.38%. In the fiscal year ending Dec 31, 2024, Axsome Therapeutics had annual revenue of 385.69M with 42.53% growth.